| Year |
Citation |
Score |
| 2023 |
Dahlbäck B. Natural anticoagulant discovery, the gift that keeps on giving: finding FV-Short. Journal of Thrombosis and Haemostasis : Jth. PMID 36746318 DOI: 10.1016/j.jtha.2023.01.033 |
0.371 |
|
| 2022 |
Dahlbäck B, Tran S. A hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S. Journal of Thrombosis and Haemostasis : Jth. PMID 35247027 DOI: 10.1111/jth.15690 |
0.337 |
|
| 2021 |
Dahlbäck B, Tran S. The preAR2 region (1458-1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα. Journal of Thrombosis and Haemostasis : Jth. PMID 34623729 DOI: 10.1111/jth.15547 |
0.348 |
|
| 2020 |
Dahlbäck B. Advances in Understanding Mechanisms of Thrombophilic Disorders. Hamostaseologie. 40: 12-21. PMID 31994161 DOI: 10.1055/S-0040-1701612 |
0.426 |
|
| 2019 |
Dahlbäck B, Guo LJ, Zöller B, Tran S. New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short. Journal of Thrombosis and Haemostasis : Jth. PMID 30740865 DOI: 10.1111/Jth.14405 |
0.45 |
|
| 2018 |
Dahlbäck B. Treating hemophilia by targeting protein S? Blood. 131: 1271-1272. PMID 29567756 DOI: 10.1182/Blood-2018-01-828152 |
0.314 |
|
| 2017 |
Dahlbäck B. Vitamin K-Dependent Protein S: Beyond the Protein C Pathway. Seminars in Thrombosis and Hemostasis. PMID 28905350 DOI: 10.1055/S-0037-1604092 |
0.446 |
|
| 2017 |
Dahlbäck B. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S Journal of Thrombosis and Haemostasis. 15: 1241-1250. PMID 28671348 DOI: 10.1111/Jth.13665 |
0.48 |
|
| 2017 |
Lundqvist M, Augustsson C, Lilja M, Lundkvist K, Dahlbäck B, Linse S, Cedervall T. The nanoparticle protein corona formed in human blood or human blood fractions. Plos One. 12: e0175871. PMID 28414772 DOI: 10.1371/Journal.Pone.0175871 |
0.321 |
|
| 2016 |
Dahlbäck B. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders. International Journal of Laboratory Hematology. PMID 27161771 DOI: 10.1111/Ijlh.12508 |
0.399 |
|
| 2016 |
Happonen KE, Tran S, Morgelin M, Prince R, Calzavarini S, Angelillo-Scherrer A, Dahlback B. The Gas6-Axl Interaction Mediates Endothelial Uptake of Platelet Microparticles. The Journal of Biological Chemistry. PMID 27006397 DOI: 10.1074/Jbc.M115.699058 |
0.33 |
|
| 2016 |
Frej C, Linder A, Happonen KE, Taylor FB, Lupu F, Dahlbäck B. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons. Journal of Cellular and Molecular Medicine. PMID 26990127 DOI: 10.1111/Jcmm.12831 |
0.311 |
|
| 2015 |
Somajo S, Ahnström J, Fernandez-Recio J, Gierula M, Villoutreix BO, Dahlbäck B. Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction. Thrombosis and Haemostasis. 113: 976-87. PMID 25716664 DOI: 10.1160/Th14-09-0803 |
0.441 |
|
| 2014 |
Koshiar RL, Somajo S, Norström E, Dahlbäck B. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation. Plos One. 9: e104200. PMID 25136857 DOI: 10.1371/Journal.Pone.0104200 |
0.455 |
|
| 2014 |
Somajo S, Koshiar RL, Norström E, Dahlbäck B. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C. Thrombosis Research. 134: 144-52. PMID 24835672 DOI: 10.1016/J.Thromres.2014.04.031 |
0.443 |
|
| 2014 |
Reglińska-Matveyev N, Andersson HM, Rezende SM, Dahlbäck B, Crawley JT, Lane DA, Ahnström J. TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain. Blood. 123: 3979-87. PMID 24740810 DOI: 10.1182/Blood-2014-01-551812 |
0.438 |
|
| 2014 |
Dahlbäck B. Targeting exosites of activated protein C as therapeutic possibility? Thrombosis Research. 133: 963-4. PMID 24612601 DOI: 10.1016/J.Thromres.2014.02.013 |
0.37 |
|
| 2013 |
Vincent LM, Tran S, Livaja R, Bensend TA, Milewicz DM, Dahlbäck B. Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα. The Journal of Clinical Investigation. 123: 3777-87. PMID 23979162 DOI: 10.1172/Jci69091 |
0.35 |
|
| 2013 |
Calzavarini S, Villoutreix BO, Lunghi B, Livaja R, Bernardi F, Dahlbäck B. Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation. Thrombosis and Haemostasis. 110: 31-8. PMID 23616041 DOI: 10.1160/Th12-10-0780 |
0.355 |
|
| 2012 |
Zöller B, Holm J, Dahlbäck B. Resistance to activated protein C due to a factor V gene mutation The most common inherited risk factor of thrombosis. Trends in Cardiovascular Medicine. 6: 45-53. PMID 21232274 DOI: 10.1016/1050-1738(95)00130-1 |
0.451 |
|
| 2011 |
Dahlbäck B. C4b-binding protein: a forgotten factor in thrombosis and hemostasis. Seminars in Thrombosis and Hemostasis. 37: 355-61. PMID 21805441 DOI: 10.1055/S-0031-1276584 |
0.457 |
|
| 2011 |
Ahnström J, Andersson HM, Canis K, Norstrøm E, Yu Y, Dahlbäck B, Panico M, Morris HR, Crawley JT, Lane DA. Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue. Blood. 117: 6685-93. PMID 21508412 DOI: 10.1182/Blood-2010-11-317099 |
0.465 |
|
| 2010 |
Yamazaki T, Okada H, Balling KW, Dahlbäck B, Nicolaes GA. The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype. Thrombosis and Haemostasis. 104: 860-1. PMID 20694279 DOI: 10.1160/Th10-03-0180 |
0.637 |
|
| 2010 |
Hafizi S, Gustafsson A, Oslakovic C, Idevall-Hagren O, Tengholm A, Sperandio O, Villoutreix BO, Dahlbäck B. Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membrane. Biochemical and Biophysical Research Communications. 399: 396-401. PMID 20678486 DOI: 10.1016/J.Bbrc.2010.07.085 |
0.331 |
|
| 2010 |
Nicolaes GA, Bock PE, Segers K, Wildhagen KC, Dahlbäck B, Rosing J. Inhibition of thrombin formation by active site mutated (S360A) activated protein C. The Journal of Biological Chemistry. 285: 22890-900. PMID 20484050 DOI: 10.1074/Jbc.M110.131029 |
0.766 |
|
| 2010 |
Oslakovic C, Norstrøm E, Dahlbäck B. Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans. The Journal of Clinical Investigation. 120: 1396-9. PMID 20446351 DOI: 10.1172/Jci42260 |
0.397 |
|
| 2010 |
Andersson HM, Arantes MJ, Crawley JT, Luken BM, Tran S, Dahlbäck B, Lane DA, Rezende SM. Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain. Blood. 115: 4878-85. PMID 20308596 DOI: 10.1182/Blood-2009-11-256610 |
0.478 |
|
| 2010 |
Lindqvist PG, Balogh I, Dahlbäck B. Umbilical cord plasma levels of growth-arrest specific protein 6 in intrauterine growth restriction. Acta Obstetricia Et Gynecologica Scandinavica. 89: 22-6. PMID 19916876 DOI: 10.3109/00016340903410899 |
0.315 |
|
| 2010 |
Hafizi S, Sernstad E, Swinny JD, Gomez MF, Dahlbäck B. Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects. The International Journal of Biochemistry & Cell Biology. 42: 52-61. PMID 19747564 DOI: 10.1016/J.Biocel.2009.09.005 |
0.335 |
|
| 2010 |
Oslakovic C, Jauhiainen M, Ehnholm C, Dahlback B. P233 ACTIVE PHOSPHOLIPID TRANSFER PROTEIN (PLTP) REDUCES PROTHROMBIN ACTIVATION AND ATTENUATES BLOOD COAGULATION Atherosclerosis Supplements. 11: 65. DOI: 10.1016/S1567-5688(10)70300-7 |
0.351 |
|
| 2009 |
Tran S, Dahlbäck B. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S. Journal of Thrombosis and Haemostasis : Jth. 8: 129-36. PMID 19874463 DOI: 10.1111/J.1538-7836.2009.03657.X |
0.409 |
|
| 2009 |
Krisinger MJ, Guo LJ, Salvagno GL, Guidi GC, Lippi G, Dahlbäck B. Mouse recombinant protein C variants with enhanced membrane affinity and hyper-anticoagulant activity in mouse plasma. The Febs Journal. 276: 6586-602. PMID 19817854 DOI: 10.1111/J.1742-4658.2009.07371.X |
0.46 |
|
| 2009 |
Sevvana M, Ahnström J, Egerer-Sieber C, Lange HA, Dahlbäck B, Muller YA. Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M. Journal of Molecular Biology. 393: 920-36. PMID 19733574 DOI: 10.1016/J.Jmb.2009.08.071 |
0.321 |
|
| 2009 |
Nielsen LB, Christoffersen C, Ahnström J, Dahlbäck B. ApoM: gene regulation and effects on HDL metabolism. Trends in Endocrinology and Metabolism: Tem. 20: 66-71. PMID 19200746 DOI: 10.1016/J.Tem.2008.11.003 |
0.309 |
|
| 2009 |
Preston RJ, Tran S, Johnson JA, Ní Áinle F, Harmon S, White B, Smith OP, Jenkins PV, Dahlbäck B, O'Donnell JS. Platelet factor 4 impairs the anticoagulant activity of activated protein C. The Journal of Biological Chemistry. 284: 5869-75. PMID 19129181 DOI: 10.1074/Jbc.M804703200 |
0.484 |
|
| 2009 |
Oslakovic C, Krisinger MJ, Andersson A, Jauhiainen M, Ehnholm C, Dahlbäck B. Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins. The Journal of Biological Chemistry. 284: 5896-904. PMID 19129179 DOI: 10.1074/Jbc.M807286200 |
0.346 |
|
| 2009 |
Oslakovic C, Krisinger M, Jauhiainen M, Ehnholm C, Dahlbäck B. Abstract: 614 ANTICOAGULANT PROPERTIES OF APOLIPOPROTEIN A-I AND PHOSPHOLIPID TRANSFER PROTEIN Atherosclerosis Supplements. 10: 138-138. DOI: 10.1016/S1567-5688(09)70143-6 |
0.32 |
|
| 2008 |
Malm K, Arnljots B, Dahlbäck B. Human activated protein C variants in a rat model of arterial thrombosis. Thrombosis Journal. 6: 16. PMID 18957140 DOI: 10.1186/1477-9560-6-16 |
0.457 |
|
| 2008 |
Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 112: 19-27. PMID 18574041 DOI: 10.1182/Blood-2008-01-077909 |
0.372 |
|
| 2008 |
Lindqvist PG, Dahlbäck B. Carriership of Factor V Leiden and evolutionary selection advantage. Current Medicinal Chemistry. 15: 1541-4. PMID 18537629 DOI: 10.2174/092986708784638852 |
0.303 |
|
| 2008 |
Segers K, Dahlbäck B, Rosing J, Nicolaes GA. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin. The Journal of Biological Chemistry. 283: 22573-81. PMID 18519572 DOI: 10.1074/Jbc.M801724200 |
0.756 |
|
| 2008 |
Steen M, Tran S, Autin L, Villoutreix BO, Tholander AL, Dahlbäck B. Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis. The Journal of Biological Chemistry. 283: 20805-12. PMID 18502757 DOI: 10.1074/Jbc.M802703200 |
0.341 |
|
| 2008 |
Christoffersen C, Ahnström J, Axler O, Christensen EI, Dahlbäck B, Nielsen LB. The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma. The Journal of Biological Chemistry. 283: 18765-72. PMID 18460466 DOI: 10.1074/Jbc.M800695200 |
0.301 |
|
| 2008 |
Tran S, Norstrøm E, Dahlbäck B. Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va. The Journal of Biological Chemistry. 283: 6648-55. PMID 18198180 DOI: 10.1074/Jbc.M708036200 |
0.434 |
|
| 2008 |
Maurissen LF, Thomassen MC, Nicolaes GA, Dahlbäck B, Tans G, Rosing J, Hackeng TM. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood. 111: 3034-41. PMID 18160668 DOI: 10.1182/Blood-2007-06-089987 |
0.763 |
|
| 2008 |
Dahlbäck B, Ahnström J, Christoffersen C, Nielsen LB. Apolipoprotein M: structure and function Future Lipidology. 3: 495-503. DOI: 10.2217/17460875.3.5.495 |
0.308 |
|
| 2008 |
Dahlbäck B. Early days of APC resistance and FV Leiden HäMostaseologie. 28: 103-109. DOI: 10.1055/S-0037-1617167 |
0.357 |
|
| 2007 |
Segers K, Dahlbäck B, Bock PE, Tans G, Rosing J, Nicolaes GA. The role of thrombin exosites I and II in the activation of human coagulation factor V. The Journal of Biological Chemistry. 282: 33915-24. PMID 17878169 DOI: 10.1074/Jbc.M701123200 |
0.744 |
|
| 2007 |
Segers K, Dahlbäck B, Nicolaes GA. Coagulation factor V and thrombophilia: background and mechanisms. Thrombosis and Haemostasis. 98: 530-42. PMID 17849041 DOI: 10.1160/Th07-02-0150 |
0.697 |
|
| 2007 |
Trouw LA, Bengtsson AA, Gelderman KA, Dahlbäck B, Sturfelt G, Blom AM. C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack. The Journal of Biological Chemistry. 282: 28540-8. PMID 17699521 DOI: 10.1074/Jbc.M704354200 |
0.386 |
|
| 2007 |
Ahnström J, Faber K, Axler O, Dahlbäck B. Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M. Journal of Lipid Research. 48: 1754-62. PMID 17525477 DOI: 10.1194/Jlr.M700103-Jlr200 |
0.337 |
|
| 2007 |
Malm K, Arnljots B, Persson IM, Dahlbäck B. Antithrombotic and anticoagulant effects of wild type and Gla-domain mutated human activated protein C in rats. Thrombosis Research. 120: 531-9. PMID 17169412 DOI: 10.1016/J.Thromres.2006.11.004 |
0.35 |
|
| 2007 |
Christoffersen C, Dahlbäck B, Nielsen LB. Apolipoprotein M: progress in understanding its regulation and metabolic functions. Scandinavian Journal of Clinical and Laboratory Investigation. 66: 631-7. PMID 17101555 DOI: 10.1080/00365510600885500 |
0.318 |
|
| 2007 |
Dahlbäck B. The tale of protein S and C4b-binding protein, a story of affection Thrombosis and Haemostasis. 98: 90-96. DOI: 10.1160/Th07-04-0269 |
0.411 |
|
| 2007 |
Segers K, Dahlbäck B, Nicolaes G. Coagulation factor V and thrombophilia: Background and mechanisms Thrombosis and Haemostasis. 98: 530-542. DOI: 10.1160/TH07-02-0150 |
0.316 |
|
| 2007 |
Maurissen L, Thomassen S, Nicolaes G, Dahlbäck B, Tans G, Rosing J, Hackeng T. PROTEIN S-C4BP COMPLEX STIMULATES ACTIVATED PROTEIN C-MEDIATED INACTIVATION AT R306 BUT INHIBITS INACTIVATION AT R506 IN FACTOR VA Journal of Thrombosis and Haemostasis. 5: P-M-082-P-M-082. DOI: 10.1111/J.1538-7836.2007.Tb01004.X |
0.737 |
|
| 2007 |
Dahlback B. Vitamin k–dependent anticoagulant protein S Endothelial Biomedicine. 982-987. DOI: 10.1017/CBO9780511546198.110 |
0.336 |
|
| 2006 |
Hafizi S, Dahlbäck B. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. The Febs Journal. 273: 5231-44. PMID 17064312 DOI: 10.1111/J.1742-4658.2006.05529.X |
0.376 |
|
| 2006 |
Norstrøm EA, Tran S, Steen M, Dahlbäck B. Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va. The Journal of Biological Chemistry. 281: 31486-94. PMID 16935856 DOI: 10.1074/Jbc.M606441200 |
0.464 |
|
| 2006 |
Preston RJ, Ajzner E, Razzari C, Karageorgi S, Dua S, Dahlbäck B, Lane DA. Multifunctional specificity of the protein C/activated protein C Gla domain. The Journal of Biological Chemistry. 281: 28850-7. PMID 16867987 DOI: 10.1074/Jbc.M604966200 |
0.462 |
|
| 2006 |
Autin L, Steen M, Dahlbäck B, Villoutreix BO. Proposed structural models of the prothrombinase (FXa-FVa) complex. Proteins. 63: 440-50. PMID 16437549 DOI: 10.1002/Prot.20848 |
0.32 |
|
| 2006 |
Lindqvist PG, Svensson P, Dahlbäck B. Activated protein C resistance -- in the absence of factor V Leiden -- and pregnancy. Journal of Thrombosis and Haemostasis : Jth. 4: 361-6. PMID 16420566 DOI: 10.1111/J.1538-7836.2006.01714.X |
0.382 |
|
| 2006 |
Faber K, Hvidberg V, Moestrup SK, Dahlbäck B, Nielsen LB. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M. Molecular Endocrinology (Baltimore, Md.). 20: 212-8. PMID 16099815 DOI: 10.1210/Me.2005-0209 |
0.327 |
|
| 2005 |
Johansson AM, Hillarp A, Säll T, Zöller B, Dahlbäck B, Halldén C. Large deletions of the PROS1 gene in a large fraction of mutation-negative patients with protein S deficiency. Thrombosis and Haemostasis. 94: 951-7. PMID 16363235 DOI: 10.1160/Th05-06-0392 |
0.339 |
|
| 2005 |
Dahlbäck B. The importance of the protein C system in the pathogenesis of venous thrombosis. Hematology (Amsterdam, Netherlands). 10: 138-9. PMID 16188655 DOI: 10.1080/10245330512331390195 |
0.517 |
|
| 2005 |
Hafizi S, Gustafsson A, Stenhoff J, Dahlbäck B. The Ran binding protein RanBPM interacts with Axl and Sky receptor tyrosine kinases. The International Journal of Biochemistry & Cell Biology. 37: 2344-56. PMID 15964779 DOI: 10.1016/J.Biocel.2005.05.006 |
0.349 |
|
| 2005 |
Dahlbäck B, Villoutreix BO. The anticoagulant protein C pathway. Febs Letters. 579: 3310-6. PMID 15943976 DOI: 10.1016/J.Febslet.2005.03.001 |
0.475 |
|
| 2005 |
Dahlbäck B, Villoutreix BO. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 1311-20. PMID 15860736 DOI: 10.1161/01.Atv.0000168421.13467.82 |
0.473 |
|
| 2005 |
Hafizi S, Ibraimi F, Dahlbäck B. C1-TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 971-3. PMID 15817639 DOI: 10.1096/Fj.04-2532Fje |
0.338 |
|
| 2005 |
Balogh I, Hafizi S, Stenhoff J, Hansson K, Dahlbäck B. Analysis of Gas6 in human platelets and plasma. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 1280-6. PMID 15790929 DOI: 10.1161/01.Atv.0000163845.07146.48 |
0.308 |
|
| 2005 |
Preston RJ, Villegas-Mendez A, Sun YH, Hermida J, Simioni P, Philippou H, Dahlbäck B, Lane DA. Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation. The Febs Journal. 272: 97-108. PMID 15634335 DOI: 10.1111/J.1432-1033.2004.04401.X |
0.46 |
|
| 2005 |
Lanke E, Johansson AM, Hillarp A, Lethagen S, Zöller B, Dahlbäck B, Halldén C. Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1. Journal of Thrombosis and Haemostasis : Jth. 2: 1918-23. PMID 15550022 DOI: 10.1111/J.1538-7836.2004.00950.X |
0.391 |
|
| 2004 |
Jeimy SB, Woram RA, Fuller N, Quinn-Allen MA, Nicolaes GA, Dahlbäck B, Kane WH, Hayward CP. Identification of the MMRN1 binding region within the C2 domain of human factor V. The Journal of Biological Chemistry. 279: 51466-71. PMID 15452129 DOI: 10.1074/jbc.M409866200 |
0.655 |
|
| 2004 |
Sun YH, Tran S, Norstrøm EA, Dahlbäck B. Enhanced rate of cleavage at Arg-306 and Arg-506 in coagulation factor Va by Gla domain-mutated human-activated protein C. The Journal of Biological Chemistry. 279: 47528-35. PMID 15337738 DOI: 10.1074/Jbc.M407366200 |
0.475 |
|
| 2004 |
Nicolaes GA, Sørensen KW, Friedrich U, Tans G, Rosing J, Autin L, Dahlbäck B, Villoutreix BO. Altered inactivation pathway of factor Va by activated protein C in the presence of heparin. European Journal of Biochemistry / Febs. 271: 2724-36. PMID 15206937 DOI: 10.1111/J.1432-1033.2004.04201.X |
0.733 |
|
| 2004 |
Stenhoff J, Dahlbäck B, Hafizi S. Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts. Biochemical and Biophysical Research Communications. 319: 871-8. PMID 15184064 DOI: 10.1016/J.Bbrc.2004.05.070 |
0.315 |
|
| 2004 |
Blom AM, Villoutreix BO, Dahlbäck B. Functions of human complement inhibitor C4b-binding protein in relation to its structure. Archivum Immunologiae Et Therapiae Experimentalis. 52: 83-95. PMID 15179322 |
0.319 |
|
| 2004 |
Sørensen KW, Nicolaes GA, Villoutreix BO, Yamazaki T, Tans G, Rosing J, Dahlbäck B. Functional properties of recombinant factor V mutated in a potential calcium-binding site. Biochemistry. 43: 5803-10. PMID 15134454 DOI: 10.1021/Bi0361362 |
0.733 |
|
| 2004 |
Kask L, Trouw LA, Dahlbäck B, Blom AM. The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. The Journal of Biological Chemistry. 279: 23869-73. PMID 15096498 DOI: 10.1074/Jbc.C400159200 |
0.361 |
|
| 2004 |
Kask L, Villoutreix BO, Steen M, Ramesh B, Dahlbäck B, Blom AM. Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H. Protein Science : a Publication of the Protein Society. 13: 1356-64. PMID 15075409 DOI: 10.1110/Ps.03516504 |
0.4 |
|
| 2004 |
Blom AM, Villoutreix BO, Dahlbäck B. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? Molecular Immunology. 40: 1333-46. PMID 15072852 DOI: 10.1016/J.Molimm.2003.12.002 |
0.392 |
|
| 2004 |
Dahlbäck B. Progress in the understanding of the protein C anticoagulant pathway. International Journal of Hematology. 79: 109-16. PMID 15005336 DOI: 10.1532/Ijh97.03149 |
0.46 |
|
| 2004 |
Steen M, Norstrøm EA, Tholander AL, Bolton-Maggs PH, Mumford A, McVey JH, Tuddenham EG, Dahlbäck B. Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis. Blood. 103: 3381-7. PMID 14695241 DOI: 10.1182/Blood-2003-06-2092 |
0.409 |
|
| 2004 |
Malm K, Dahlbäck B, Arnljots B. Prevention of thrombosis following deep arterial injury in rats by bovine activated protein C requiring co-administration of bovine protein S. Thrombosis and Haemostasis. 90: 227-34. PMID 12888869 DOI: 10.1160/Th03-03-0174 |
0.359 |
|
| 2004 |
Jeimy SB, Woram RA, Fuller N, Quinn-Allen MA, Nicolaes G, Dahlback B, Kane WH, Hayward CP. Identification of the Multimerin Binding Region within the C2 Domain of Human Factor V Using Constructs Generated by Alanine-Scanning and Site-Directed Mutagenesis. Blood. 104: 124-124. DOI: 10.1182/Blood.V104.11.124.124 |
0.408 |
|
| 2004 |
Dahlback B. Anticoagulant factor V and thrombosis risk Blood. 103: 3995-3995. DOI: 10.1182/Blood-2004-03-1079 |
0.399 |
|
| 2004 |
DAHLBACK B. The multiple faces of the partial thromboplastin time APTT Journal of Thrombosis and Haemostasis. 2: 2256-2257. DOI: 10.1111/J.1538-7836.2004.00998.X |
0.308 |
|
| 2003 |
Nicolaes GA, Dahlbäck B. Congenital and acquired activated protein C resistance. Seminars in Vascular Medicine. 3: 33-46. PMID 15199491 DOI: 10.1055/S-2003-38331 |
0.697 |
|
| 2003 |
Mumford AD, McVey JH, Morse CV, Gomez K, Steen M, Norstrom EA, Tuddenham EG, Dahlback B, Bolton-Maggs PH. Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C. British Journal of Haematology. 123: 496-501. PMID 14617013 DOI: 10.1046/J.1365-2141.2003.04624.X |
0.438 |
|
| 2003 |
Webb JH, Blom AM, Dahlbäck B. The binding of protein S and the protein S-C4BP complex to neutrophils is apoptosis dependent. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 14: 355-9. PMID 12945877 DOI: 10.1097/00001721-200306000-00006 |
0.308 |
|
| 2003 |
Dahlbäck B. The discovery of activated protein C resistance. Journal of Thrombosis and Haemostasis : Jth. 1: 3-9. PMID 12871530 DOI: 10.1046/J.1538-7836.2003.00016.X |
0.399 |
|
| 2003 |
Herwald H, Mörgelin M, Dahlbäck B, Björck L. Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma. Journal of Thrombosis and Haemostasis : Jth. 1: 284-91. PMID 12871502 DOI: 10.1046/J.1538-7836.2003.00105.X |
0.351 |
|
| 2003 |
Ajzner E, Balogh I, Haramura G, Boda Z, Kalmár K, Pfliegler G, Dahlbäck B, Muszbek L. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding. Journal of Thrombosis and Haemostasis : Jth. 1: 943-9. PMID 12871359 DOI: 10.1046/J.1538-7836.2003.00143.X |
0.33 |
|
| 2003 |
Dahlbäck B, Villoutreix BO. Molecular recognition in the protein C anticoagulant pathway. Journal of Thrombosis and Haemostasis : Jth. 1: 1525-34. PMID 12871288 DOI: 10.1046/J.1538-7836.2003.00299.X |
0.446 |
|
| 2003 |
Steen M, Miteva M, Villoutreix BO, Yamazaki T, Dahlbäck B. Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized. Blood. 102: 1316-22. PMID 12714495 DOI: 10.1182/Blood-2003-01-0116 |
0.394 |
|
| 2003 |
Norstrøm EA, Steen M, Tran S, Dahlbäck B. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va. The Journal of Biological Chemistry. 278: 24904-11. PMID 12707283 DOI: 10.1074/Jbc.M303829200 |
0.45 |
|
| 2003 |
Persson KE, Dahlbäck B, Hillarp A. Diagnosing protein S deficiency: analytical considerations. Clinical Laboratory. 49: 103-10. PMID 12705691 |
0.329 |
|
| 2003 |
Dahlbäck B. Successful hunt for quantitative trait locus in thrombophilia. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 376-7. PMID 12639827 DOI: 10.1161/01.Atv.0000061495.19622.B9 |
0.402 |
|
| 2003 |
Nicolaes GA, Dahlbäck B. Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states. Hematology/Oncology Clinics of North America. 17: 37-61, vi. PMID 12627662 DOI: 10.1016/S0889-8588(02)00097-7 |
0.694 |
|
| 2003 |
Webb JH, Villoutreix BO, Dahlbäck B, Blom AM. Role of CCP2 of the C4b-binding protein beta-chain in protein S binding evaluated by mutagenesis and monoclonal antibodies. European Journal of Biochemistry. 270: 93-100. PMID 12492479 DOI: 10.1046/J.1432-1033.2003.03365.X |
0.406 |
|
| 2003 |
Hafizi S, Alindri F, Karlsson R, Dahlbäck B. Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin. Biochemical and Biophysical Research Communications. 299: 793-800. PMID 12470648 DOI: 10.1016/S0006-291X(02)02718-3 |
0.406 |
|
| 2003 |
Blom AM, Kask L, Dahlbäck B. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b. Molecular Immunology. 39: 547-56. PMID 12431388 DOI: 10.1016/S0161-5890(02)00213-4 |
0.38 |
|
| 2003 |
Webb JH, Blom AM, Dahlbäck B. The binding of protein S and the protein S-C4BP complex to neutrophils is apoptosis dependent. Blood Coagulation & Fibrinolysis. 14: 355-359. DOI: 10.1097/01.Mbc.0000061318.06975.A4 |
0.421 |
|
| 2002 |
Sun YH, Shen L, Dahlbäck B. Gla domain-mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding. Blood. 101: 2277-84. PMID 12446455 DOI: 10.1182/Blood-2002-06-1691 |
0.465 |
|
| 2002 |
Yamazaki T, Nicolaes GA, Sørensen KW, Dahlbäck B. Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype. Blood. 100: 2515-21. PMID 12239164 DOI: 10.1182/Blood.V100.7.2515 |
0.657 |
|
| 2002 |
Webb JH, Blom AM, Dahlbäck B. Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells. Journal of Immunology (Baltimore, Md. : 1950). 169: 2580-6. PMID 12193728 DOI: 10.4049/jimmunol.169.5.2580 |
0.317 |
|
| 2002 |
Steen M, Dahlbäck B. Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site. The Journal of Biological Chemistry. 277: 38424-30. PMID 12163491 DOI: 10.1074/Jbc.M204972200 |
0.389 |
|
| 2002 |
Lindqvist PG, Olofsson P, Dahlbäck B. Use of selective factor V Leiden screening in pregnancy to identify candidates for anticoagulants. Obstetrics and Gynecology. 100: 332-6. PMID 12151159 DOI: 10.1016/S0029-7844(02)02092-6 |
0.316 |
|
| 2002 |
Kask L, Hillarp A, Ramesh B, Dahlbäck B, Blom AM. Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein. Biochemistry. 41: 9349-57. PMID 12135356 DOI: 10.1021/Bi025980+ |
0.314 |
|
| 2002 |
Norstrøm E, Thorelli E, Dahlbäck B. Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood. 100: 524-30. PMID 12091344 DOI: 10.1182/Blood-2002-02-0343 |
0.452 |
|
| 2002 |
Nicolaes GA, Dahlbäck B. Factor V and thrombotic disease: description of a janus-faced protein. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 530-8. PMID 11950687 DOI: 10.1161/01.Atv.0000012665.51263.B7 |
0.687 |
|
| 2002 |
Giri TK, Linse S, García de Frutos P, Yamazaki T, Villoutreix BO, Dahlbäck B. Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b-binding protein. The Journal of Biological Chemistry. 277: 15099-106. PMID 11847209 DOI: 10.1074/jbc.M103036200 |
0.328 |
|
| 2002 |
Sales M, Chitolie A, Domènech P, Rossi E, Borrell M, Dahlbäck B, Serra J. Multicentre Evaluation of IL Test™ Free PS: A Fully Automated Assay to Quantify Free Protein S Thrombosis and Haemostasis. 88: 975-983. DOI: 10.1055/S-0037-1613343 |
0.369 |
|
| 2002 |
Yamazaki T, Saito H, Dahlbäck B. Rapid Intracellular Degradation of a Truncated Mutant Protein S (Q522X) Thrombosis and Haemostasis. 87: 171-172. DOI: 10.1055/S-0037-1612963 |
0.382 |
|
| 2001 |
Berggård K, Lindahl G, Dahlbäck B, Blom AM. Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b. European Journal of Immunology. 31: 2771-80. PMID 11536176 DOI: 10.1002/1521-4141(200109)31:9<2771::Aid-Immu2771>3.0.Co;2-0 |
0.385 |
|
| 2001 |
Duan J, Dahlbäck B, Villoutreix BO. Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis. Febs Letters. 499: 127-32. PMID 11418126 DOI: 10.1016/S0014-5793(01)02544-3 |
0.312 |
|
| 2001 |
Blom AM, Kask L, Dahlbäck B. Structural requirements for the complement regulatory activities of C4BP. The Journal of Biological Chemistry. 276: 27136-44. PMID 11369776 DOI: 10.1074/Jbc.M102445200 |
0.364 |
|
| 2001 |
Blom AM, Rytkönen A, Vasquez P, Lindahl G, Dahlbäck B, Jonsson AB. A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4B-binding protein. Journal of Immunology (Baltimore, Md. : 1950). 166: 6764-70. PMID 11359834 DOI: 10.4049/Jimmunol.166.11.6764 |
0.376 |
|
| 2001 |
Friedrich U, Blom AM, Dahlbäck B, Villoutreix BO. Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C. The Journal of Biological Chemistry. 276: 24122-8. PMID 11316800 DOI: 10.1074/Jbc.M011567200 |
0.412 |
|
| 2001 |
Friedrich U, Nicolaes GA, Villoutreix BO, Dahlbäck B. Secondary substrate-binding exosite in the serine protease domain of activated protein C important for cleavage at Arg-506 but not at Arg-306 in factor Va. The Journal of Biological Chemistry. 276: 23105-8. PMID 11309403 DOI: 10.1074/jbc.M103138200 |
0.673 |
|
| 2001 |
Villoutreix BO, Dahlbäck B, Borgel D, Gandrille S, Muller YA. Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights. Proteins. 43: 203-16. PMID 11276089 DOI: 10.1002/1097-0134(20010501)43:2<203::Aid-Prot1031>3.0.Co;2-W |
0.401 |
|
| 2001 |
Villoutreix BO, Covell DG, Blom AM, Wallqvist A, Friedrich U, Dahlbäck B. Screening the molecular surface of human anticoagulant protein C: a search for interaction sites. Journal of Computer-Aided Molecular Design. 15: 13-27. PMID 11219426 DOI: 10.1023/A:1011158717139 |
0.394 |
|
| 2001 |
Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, Monks BG, O'Connell C, Boden R, Elkins C, Pangburn MK, Dahlbäck B, Rice PA. Binding of C4b-binding protein to porin: A molecular mechanism of serum resistance of Neisseria gonorrhoeae Journal of Experimental Medicine. 193: 281-295. PMID 11157049 DOI: 10.1084/Jem.193.3.281 |
0.336 |
|
| 2001 |
Hillarp A, Dahlbäck B, Persson K. Analytical Considerations for Free Protein S Assays in Protein S Deficiency Thrombosis and Haemostasis. 86: 1144-1147. DOI: 10.1055/S-0037-1616042 |
0.412 |
|
| 2000 |
Blom AM, Zadura AF, Villoutreix BO, Dahlbäck B. Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase. Molecular Immunology. 37: 445-53. PMID 11090879 DOI: 10.1016/S0161-5890(00)00059-6 |
0.406 |
|
| 2000 |
Evenäs P, García de Frutos P, Nicolaes GA, Dahlbäck B. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa. Thrombosis and Haemostasis. 84: 271-7. PMID 10959700 DOI: 10.1055/S-0037-1614007 |
0.702 |
|
| 2000 |
Ekberg H, Svensson PJ, Simanaitis M, Dahlbäck B. Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection. Transplantation. 69: 1577-81. PMID 10836365 DOI: 10.1097/00007890-200004270-00010 |
0.368 |
|
| 2000 |
Blom AM, Berggârd K, Webb JH, Lindahl G, Villoutreix BO, Dahlbäck B. Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins. Journal of Immunology (Baltimore, Md. : 1950). 164: 5328-36. PMID 10799895 DOI: 10.4049/Jimmunol.164.10.5328 |
0.393 |
|
| 2000 |
van de Poel RH, Meijers JC, Dahlbäck B, Bouma BN. C4b-binding protein (C4BP) beta-chain Short Consensus Repeat-2 specifically contributes to the interaction of C4BP with protein S. Blood Cells, Molecules & Diseases. 25: 279-86. PMID 10744423 DOI: 10.1006/Bcmd.1999.0255 |
0.361 |
|
| 2000 |
Shen L, Dahlbäck B, Villoutreix BO. Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin. Biochemistry. 39: 2853-60. PMID 10715104 DOI: 10.1021/Bi992357P |
0.414 |
|
| 2000 |
Nicolaes GA, Villoutreix BO, Dahlbäck B. Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 11: 89-100. PMID 10691103 DOI: 10.1097/00001721-200001000-00010 |
0.699 |
|
| 2000 |
Evenäs P, García De Frutos P, Linse S, Dahlbäck B. Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein. European Journal of Biochemistry. 266: 935-42. PMID 10583388 DOI: 10.1046/J.1432-1327.1999.00928.X |
0.403 |
|
| 2000 |
Villoutreix BO, Blom AM, Dahlbäck B. Structural prediction and analysis of endothelial cell protein C/activated protein C receptor. Protein Engineering. 12: 833-40. PMID 10556243 DOI: 10.1093/Protein/12.10.833 |
0.375 |
|
| 2000 |
Giri TK, Yamazaki T, Sala N, Dahlbäck B, de Frutos PG. Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors Blood. 96: 523-531. DOI: 10.1182/Blood.V96.2.523.014K04_523_531 |
0.469 |
|
| 2000 |
Giri T, de Frutos P, Dahlbäck B. Protein S Thr103Asn Mutation Associated with Type II Deficiency Reproduced In Vitro and Functionally Characterised Thrombosis and Haemostasis. 84: 413-419. DOI: 10.1055/S-0037-1614037 |
0.435 |
|
| 2000 |
Evenäs P, García de Frutos P, Nicolaes G, Dahlbäck B. The Second Laminin G-type Domain of Protein S Is Indispensable for Expression of Full Cofactor Activity in Activated Protein C-catalysed Inactivation of Factor Va and Factor VIIIa Thrombosis and Haemostasis. 84: 271-277. DOI: 10.1055/s-0037-1614007 |
0.322 |
|
| 2000 |
Webb J, Villoutreix B, Dahlbäck B, Blom A. Localisation of the protein S binding site on the C4BP β-chain Immunopharmacology. 49: 96. DOI: 10.1016/S0162-3109(00)80290-8 |
0.342 |
|
| 2000 |
Berggård K, Lindahl G, Dahlbäck B, Blom A. Bordetella pertussis binds to human C4BP (C4B-binding protein) at a site similar to that used by the natural ligand C4b Immunopharmacology. 49: 75. DOI: 10.1016/S0162-3109(00)80224-6 |
0.336 |
|
| 2000 |
Blom A, Villoutreix B, Webb J, Berggård K, Foltyn-Zadura A, Lindahl G, Dahlbäck B. A cluster of positively charged amino acids at the interface between C4BP CCP1 and CCP2 is crucial for binding of C4b and streptococcal proteins Immunopharmacology. 49: 74. DOI: 10.1016/S0162-3109(00)80219-2 |
0.302 |
|
| 2000 |
Ram S, Cullinane M, Gulati S, Blom A, Dahlback B, Elkins C, Pangburn M, McQuillen D, Monks B, Rice P. Stable serum resistance of Neisseria gonorrhoeae is mediated by binding of C4B-binding protein to gonococcal porin Immunopharmacology. 49: 58. DOI: 10.1016/S0162-3109(00)80164-2 |
0.357 |
|
| 1999 |
Xu N, Dahlbäck B. A novel human apolipoprotein (apoM) Journal of Biological Chemistry. 274: 31286-31290. PMID 10531326 DOI: 10.1074/Jbc.274.44.31286 |
0.355 |
|
| 1999 |
Nicolaes GA, Villoutreix BO, Dahlbäck B. Partial glycosylation of Asn2181 in human factor V as a cause of molecular and functional heterogeneity. Modulation of glycosylation efficiency by mutagenesis of the consensus sequence for N-linked glycosylation. Biochemistry. 38: 13584-91. PMID 10521265 DOI: 10.1021/Bi991165R |
0.673 |
|
| 1999 |
Dahlbäck B. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Seminars in Thrombosis and Hemostasis. 25: 273-89. PMID 10443959 DOI: 10.1055/S-2007-994931 |
0.467 |
|
| 1999 |
Villoutreix BO, Blom AM, Webb J, Dahlbäck B. The complement regulator C4b-binding protein analyzed by molecular modeling, bioinformatics and computer-aided experimental design. Immunopharmacology. 42: 121-34. PMID 10408373 DOI: 10.1016/S0162-3109(99)00022-3 |
0.394 |
|
| 1999 |
Blom AM, Webb J, Villoutreix BO, Dahlbäck B. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function. The Journal of Biological Chemistry. 274: 19237-45. PMID 10383431 DOI: 10.1074/Jbc.274.27.19237 |
0.391 |
|
| 1999 |
Dahlbäck B. Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms. The Journal of Laboratory and Clinical Medicine. 133: 415-22. PMID 10235124 DOI: 10.1016/S0022-2143(99)90018-5 |
0.318 |
|
| 1999 |
Knobe KE, Berntsdotter A, Shen L, Morser J, Dahlbäck B, Villoutreix BO. Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling. Proteins. 35: 218-34. PMID 10223294 DOI: 10.1002/(Sici)1097-0134(19990501)35:2<218::Aid-Prot8>3.0.Co;2-2 |
0.37 |
|
| 1999 |
Giri T, de Frutos PG, Yamazaki T, Villoutreix B, Dahlbäck B. In Vitro Characterisation of Two Naturally Occurring Mutations in the Thrombin-sensitive Region of Anticoagulant Protein S Thrombosis and Haemostasis. 82: 1627-1633. DOI: 10.1055/S-0037-1614890 |
0.44 |
|
| 1999 |
Shen L, Villoutreix BO, Dahlbäck B. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor. Thrombosis and Haemostasis. 82: 72-79. DOI: 10.1055/S-0037-1614632 |
0.385 |
|
| 1999 |
Hillarp A, Zöller B, Erhardt L, Berntorp E, Dahlbäck B, Holm J. Factor V Q506 (Resistance to Activated Protein C) and Prognosis after Acute Coronary Syndrome Thrombosis and Haemostasis. 81: 857-860. DOI: 10.1055/S-0037-1614587 |
0.308 |
|
| 1999 |
Lindqvist PG, Svensson PJ, Maršál K, Grennert L, Luterkort M, Dahlbäck B. Activated Protein C Resistance (FV:Q506) and Pregnancy Thrombosis and Haemostasis. 81: 532-537. DOI: 10.1055/S-0037-1614519 |
0.318 |
|
| 1999 |
Shen L, Villoutreix B, Dahlbäck B. Interspecies Loop Grafting in the Protease Domain of Human Protein C Yielding Enhanced Catalytic and Anticoagulant Activity Thrombosis and Haemostasis. 82: 1078-1087. DOI: 10.1055/S-0037-1614332 |
0.459 |
|
| 1998 |
Shen L, Shah AM, Dahlbäck B, Nelsestuen GL. Enhancement of human protein C function by site-directed mutagenesis of the gamma-carboxyglutamic acid domain. The Journal of Biological Chemistry. 273: 31086-91. PMID 9813008 DOI: 10.1074/Jbc.273.47.31086 |
0.339 |
|
| 1998 |
Sampram ESK, Lindblad B, Dahlback B. Activated protein C resistance in patients with peripheral vascular disease Journal of Vascular Surgery. 28: 624-629. PMID 9786256 DOI: 10.1016/S0741-5214(98)70086-2 |
0.33 |
|
| 1998 |
Blom AM, Covell DG, Wallqvist A, Dahlbäck B, Villoutreix BO. The C4b-binding protein-protein S interaction is hydrophobic in nature. Biochimica Et Biophysica Acta. 1388: 181-9. PMID 9774728 DOI: 10.1016/S0167-4838(98)00178-2 |
0.417 |
|
| 1998 |
He X, Shen L, Villoutreix BO, Dahlbäck B. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function. The Journal of Biological Chemistry. 273: 27449-58. PMID 9765274 DOI: 10.1074/Jbc.273.42.27449 |
0.448 |
|
| 1998 |
Nyberg P, Dahlbäck B, García de Frutos P. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function. Febs Letters. 433: 28-32. PMID 9738926 DOI: 10.1016/S0014-5793(98)00877-1 |
0.461 |
|
| 1998 |
Villoutreix BO, Dahlbäck B. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling. Protein Science : a Publication of the Protein Society. 7: 1317-25. PMID 9655335 DOI: 10.1002/Pro.5560070607 |
0.382 |
|
| 1998 |
Dahlbäck B. Commentary: Involvement of Amino Acid Residues 423-429 of Human Protein S in Binding to C4b-Binding Protein. Blood Cells Molecules and Diseases. 24: 113. PMID 9628847 DOI: 10.1006/Bcmd.1998.0177 |
0.393 |
|
| 1998 |
Villoutreix BO, Härdig Y, Wallqvist A, Covell DG, García de Frutos P, Dahlbäck B. Structural investigation of C4b-binding protein by molecular modeling: localization of putative binding sites. Proteins. 31: 391-405. PMID 9626699 DOI: 10.1002/(Sici)1097-0134(19980601)31:4<391::Aid-Prot6>3.0.Co;2-L |
0.393 |
|
| 1998 |
Herwald H, Mörgelin M, Olsén A, Rhen M, Dahlbäck B, Müller-Esterl W, Björck L. Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases Nature Medicine. 4: 298-302. PMID 9500602 DOI: 10.1038/Nm0398-298 |
0.328 |
|
| 1998 |
Stenberg Y, Drakenberg T, Dahlbäck B, Stenflo J. Characterization of recombinant epidermal growth factor (EGF)-like modules from vitamin-K-dependent protein S expressed in Spodoptera cells--the cofactor activity depends on the N-terminal EGF module in human protein S. European Journal of Biochemistry. 251: 558-64. PMID 9490026 DOI: 10.1046/J.1432-1327.1998.2510558.X |
0.612 |
|
| 1998 |
Xu N, Dahlbäck B, Ohlin AK, Nilsson A. Association of vitamin K-dependent coagulation proteins and C4b binding protein with triglyceride-rich lipoproteins of human plasma. Arteriosclerosis, Thrombosis, and Vascular Biology. 18: 33-9. PMID 9445253 DOI: 10.1161/01.ATV.18.1.33 |
0.343 |
|
| 1998 |
Shen L, Shah AM, Dahlbäck B, Nelsestuen GL. Enhancing the activity of protein C by mutagenesis to improve the membrane-binding site: studies related to proline-10. Biochemistry. 36: 16025-31. PMID 9440875 DOI: 10.1021/Bi971730V |
0.455 |
|
| 1998 |
Simmonds RE, Ireland H, Lane DA, Zöller B, García de Frutos P, Dahlbäck B. Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect. Annals of Internal Medicine. 128: 8-14. PMID 9424998 DOI: 10.7326/0003-4819-128-1-199801010-00002 |
0.375 |
|
| 1998 |
Villoutreix BO, García de Frutos P, Lövenklev M, Linse S, Fernlund P, Dahlbäck B. SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations. Proteins. 29: 478-91. PMID 9408945 DOI: 10.1002/(Sici)1097-0134(199712)29:4<478::Aid-Prot8>3.0.Co;2-4 |
0.348 |
|
| 1998 |
Zöller B, Dahlbäck B. Resistance to activated protein C caused by a factor V gene mutation. Current Opinion in Hematology. 2: 358-64. PMID 9372020 DOI: 10.1097/00062752-199502050-00006 |
0.463 |
|
| 1998 |
Hillarp A, Rosen S, Zöller B, Dahlbäck B. Resistance to activated protein C, the FV: Q506 allele, and venous thrombosis Hamostaseologie. 18: 1-10. DOI: 10.1055/S-0038-1655322 |
0.376 |
|
| 1998 |
Giri T, Villoutreix B, Wallqvist A, Dahlbäck B, Frutos PGd. Topological Studies of the Amino Terminal Modules of Vitamin K-dependent Protein S Using Monoclonal Antibody Epitope Mapping and Molecular Modeling Thrombosis and Haemostasis. 80: 798-804. DOI: 10.1055/S-0037-1615361 |
0.433 |
|
| 1998 |
Thorelli E, Kaufman R, Dahlbäck B. Cleavage Requirements of Factor V in Tissue-factor Induced Thrombin Generation Thrombosis and Haemostasis. 80: 92-98. DOI: 10.1055/S-0037-1615145 |
0.366 |
|
| 1998 |
Zöller B, Frutos PGd, Dahlbäck B. A Common 4G Allele in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene as a Risk Factor for Pulmonary Embolism and Arterial Thrombosis in Hereditary Protein S Deficiency Thrombosis and Haemostasis. 79: 802-807. DOI: 10.1055/S-0037-1615068 |
0.356 |
|
| 1998 |
Giri TK, Hillarp A, Härdig Y, Zöller B, Dahlbäck B. A New Direct, Fast and Quantitative Enzyme-linked Ligandsorbent Assay for Measurement of Free Protein S Antigen Thrombosis and Haemostasis. 79: 767-772. DOI: 10.1055/S-0037-1615062 |
0.422 |
|
| 1998 |
Svensson P, Dahlbäck B, Maršál K, Lindqvist P. Factor V Q506 Mutation (Activated Protein C Resistance) Associated with Reduced Intrapartum Blood Loss – a Possible Evolutionary Selection Mechanism Thrombosis and Haemostasis. 79: 69-73. DOI: 10.1055/S-0037-1614222 |
0.346 |
|
| 1998 |
Villoutreix B, Blom A, Dahlbäck B. Investigation of C4b-binding protein by molecular modeling Molecular Immunology. 35: 340. DOI: 10.1016/S0161-5890(98)90569-7 |
0.36 |
|
| 1998 |
Blom AM, Villoutreix BO, Dahlbäck B. Interaction between C4B-binding protein and protein S is hydrophobic in nature Molecular Immunology. 35: 339. DOI: 10.1016/S0161-5890(98)90568-5 |
0.405 |
|
| 1998 |
Villoutreix BO, Dahlbäck B. Molecular Model for the C-type Lectin Domain of Human Thrombomodulin Journal of Molecular Modeling. 4: 310-322. DOI: 10.1007/S008940050088 |
0.365 |
|
| 1998 |
Villoutreix BO, Bucher P, Hofmann K, Baumgartner S, Dahlbäck B. Molecular models for the two discoidin domains of human blood coagulation factor V Journal of Molecular Modeling. 4: 268-275. DOI: 10.1007/S008940050084 |
0.344 |
|
| 1997 |
Dahlback B. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis Journal of Internal Medicine, Supplement. 242: 1-8. PMID 9350175 |
0.355 |
|
| 1997 |
Johnsson E, Thern A, Dahlbäck B, Hedén LO, Wikström M, Lindahl G. Human C4BP binds to the hypervariable N-terminal region of many members in the streptococcal M protein family. Advances in Experimental Medicine and Biology. 418: 505-10. PMID 9331704 DOI: 10.1007/978-1-4899-1825-3_120 |
0.314 |
|
| 1997 |
Villoutreix BO, Teleman O, Dahlbäck B. A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: From biostructural pathology to specie Journal of Computer-Aided Molecular Design. 11: 293-304. PMID 9263856 DOI: 10.1023/A:1007912929828 |
0.4 |
|
| 1997 |
Thorelli E, Kaufman RJ, Dahlbäck B. Cleavage requirements for activation of factor V by factor Xa. European Journal of Biochemistry. 247: 12-20. PMID 9249003 DOI: 10.1111/J.1432-1033.1997.00012.X |
0.397 |
|
| 1997 |
Dahlback B. Resistance to activated protein C as risk factor for thrombosis: Molecular mechanisms, laboratory investigation, and clinical management Seminars in Hematology. 34: 217-234. PMID 9241707 |
0.33 |
|
| 1997 |
Nyberg P, He X, Härdig Y, Dahlbäck B, Frutos PGD. Stimulation of Sky tyrosine phosphorylation by bovine protein S--domains involved in the receptor-ligand interaction. Febs Journal. 246: 147-154. PMID 9210477 DOI: 10.1111/J.1432-1033.1997.T01-2-00147.X |
0.448 |
|
| 1997 |
Svensson PJ, Zöller B, Mattiasson I, Dahlbäck B. The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis. Journal of Internal Medicine. 241: 379-85. PMID 9183305 DOI: 10.1046/J.1365-2796.1997.124140000.X |
0.368 |
|
| 1997 |
Härdig Y, Hillarp A, Dahlbäck B. The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function. The Biochemical Journal. 469-75. PMID 9163340 DOI: 10.1042/Bj3230469 |
0.367 |
|
| 1997 |
McDonald JF, Shah AM, Schwalbe RA, Kisiel W, Dahlbäck B, Nelsestuen GL. Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site. Biochemistry. 36: 5120-7. PMID 9136872 DOI: 10.1021/Bi9626160 |
0.413 |
|
| 1997 |
He X, Shen L, Malmborg AC, Smith KJ, Dahlbäck B, Linse S. Binding site for C4b-binding protein in vitamin K-dependent protein S fully contained in carboxy-terminal laminin-G-type repeats. A study using recombinant factor IX-protein S chimeras and surface plasmon resonance. Biochemistry. 36: 3745-3754. PMID 9132028 DOI: 10.1021/Bi962315Q |
0.414 |
|
| 1997 |
Bengtsson A, Zöller B, de Frutos PG, Dahlbäck B, Sturfelt G. Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus. Lupus. 5: 598-601. PMID 9116703 DOI: 10.1177/096120339600500607 |
0.335 |
|
| 1997 |
Zöller B, Hillarp A, Dahlbäck B. Activated protein C resistance caused by a common factor V mutation has a single origin. Thrombosis Research. 85: 237-43. PMID 9058498 DOI: 10.1016/S0049-3848(97)00008-X |
0.367 |
|
| 1997 |
Zöller B, Hillarp A, Berntorp E, Dahlbäck B. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis. Annual Review of Medicine. 48: 45-58. PMID 9046944 DOI: 10.1146/Annurev.Med.48.1.45 |
0.457 |
|
| 1997 |
Dahlbäck B, Zöller B, Hillarp A. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis. Haemostasis. 301-14. PMID 8979136 DOI: 10.1159/000217311 |
0.441 |
|
| 1997 |
Hillarp A, Zöller B, Dahlbäck B. Activated protein C resistance as a basis for venous thrombosis. The American Journal of Medicine. 101: 534-40. PMID 8948278 DOI: 10.1016/S0002-9343(96)00198-2 |
0.392 |
|
| 1997 |
Holm J, Zöller B, Berntorp E, Erhardt L, Dahlbäck B. Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries. Journal of Internal Medicine. 239: 221-6. PMID 8772620 DOI: 10.1046/J.1365-2796.1996.470808000.X |
0.346 |
|
| 1997 |
Zöller B, Hillarp A, Dahlbäck B. State-of-the-Art Review: Activated Protein C Resistance: Clinical Implications Clinical and Applied Thrombosis/Hemostasis. 3: 25-32. DOI: 10.1177/107602969700300103 |
0.407 |
|
| 1997 |
Shea L, He X, Dahlbäck B. Synergistic Cofactor Function of Factor V and Protein S to Activated Protein C in the Inactivation of the Factor Villa – Factor IXa Complex Thrombosis and Haemostasis. 78: 1030-1036. DOI: 10.1055/S-0038-1657682 |
0.455 |
|
| 1997 |
Svensson PJ, Benoni G, Fredin H, Bjӧrgell O, Nilsson P, Hedlund U, Nylander G, Bergqvist D, Dahlbäck B. Female Gender and Resistance to Activated Protein C (FV:Q506) as Potential Risk Factors for Thrombosis after Elective Hip Arthroplasty Thrombosis and Haemostasis. 78: 0993-0996. DOI: 10.1055/S-0038-1657675 |
0.31 |
|
| 1997 |
Hillarp A, Zӧller B, Svensson PJ, Dahlbäck B. The 20210 A Allele of the Prothrombin Gene Is a Common Risk Factor among Swedish Outpatients with Verified Deep Venous Thrombosis Thrombosis and Haemostasis. 78: 0990-0992. DOI: 10.1055/S-0038-1657674 |
0.326 |
|
| 1997 |
Dahlbäck B. Resistance to Activated Protein C Caused by the Factor V R506Q Mutation ls a Common Risk Factor for Venous
Thrombosis Thrombosis and Haemostasis. 78: 483-488. DOI: 10.1055/S-0038-1657574 |
0.396 |
|
| 1997 |
Svensson PJ, Zöller B, Dahlbäck B. Evaluation of Original and Modified APC-Resistance Tests in Unselected Outpatients with Clinically Suspected Thrombosis and in Healthy Controls Thrombosis and Haemostasis. 77: 332-335. DOI: 10.1055/S-0038-1655964 |
0.309 |
|
| 1996 |
Hillarp A, Dahlbäck B, Zöller B. Activated protein C resistance: from phenotype to genotype and clinical practice. Blood Reviews. 9: 201-12. PMID 8839395 DOI: 10.1016/S0268-960X(95)90011-X |
0.472 |
|
| 1996 |
Härdig Y, Dahlbäck B. The amino-terminal module of the C4b-binding protein beta-chain contains the protein S-binding site. The Journal of Biological Chemistry. 271: 20861-7. PMID 8702842 DOI: 10.1074/Jbc.271.34.20861 |
0.354 |
|
| 1996 |
Dahlbäck B, Hillarp A, Rosen S, Zöller B. Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis. Annals of Hematology. 72: 166-76. PMID 8624369 DOI: 10.1007/S002770050157 |
0.469 |
|
| 1996 |
Aparicio C, Dahlbäck B. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene. The Biochemical Journal. 467-72. PMID 8573079 DOI: 10.1042/Bj3130467 |
0.405 |
|
| 1996 |
Zöller B, Holm J, Svensson P, Dahlbäck B. Elevated Levels of Prothrombin Activation Fragment 1+2 in Plasma from Patients with Heterozygous Arg506 to Gin Mutation in the Factor V Gene (APC-Resistance) and/or Inherited Protein S Deficiency Thrombosis and Haemostasis. 75: 270-274. DOI: 10.1055/S-0038-1650259 |
0.416 |
|
| 1995 |
Hardig Y, Garcia de Frutos P, Dahlback B. Expression and characterization of a recombinant C4b-binding protein lacking the β-chain Biochemical Journal. 308: 795-800. PMID 8948435 DOI: 10.1042/Bj3080795 |
0.366 |
|
| 1995 |
Dahlback B. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis Thrombosis and Haemostasis. 74: 139-148. PMID 8578447 DOI: 10.1055/S-0038-1642667 |
0.404 |
|
| 1995 |
Dahlback B. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism Journal of Internal Medicine. 237: 221-227. PMID 7891043 DOI: 10.1111/J.1365-2796.1995.Tb01170.X |
0.401 |
|
| 1995 |
He X, Shen L, Dahlback B. Expression and functional characterization of chimeras between human and bovine vitamin-K-dependent protein-S-defining modules important for the species specificity of the activated protein C cofactor activity European Journal of Biochemistry. 227: 433-440. PMID 7851419 DOI: 10.1111/J.1432-1033.1995.Tb20406.X |
0.451 |
|
| 1995 |
Dahlback B. Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism Blood. 85: 607-614. PMID 7833465 DOI: 10.1182/Blood.V85.3.607.Bloodjournal853607 |
0.413 |
|
| 1995 |
He X, Shen L, Bjartell A, Dahlback B. The gene encoding vitamin K-dependent anticoagulant protein S is expressed in multiple rabbit organs as demonstrated by Northern blotting, in situ hybridization, and immunohistochemistry Journal of Histochemistry and Cytochemistry. 43: 85-96. PMID 7822769 DOI: 10.1177/43.1.7822769 |
0.388 |
|
| 1995 |
He X, Shen L, Bjartell A, Malm J, Lilja H, Dahlbäck B. The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 43: 563-70. PMID 7769227 DOI: 10.1177/43.6.7769227 |
0.41 |
|
| 1995 |
Arnljots B, Dahlback B. Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits Journal of Clinical Investigation. 95: 1987-1993. PMID 7738165 |
0.307 |
|
| 1995 |
García de Frutos P, Dahlbäck B. cDNA structure of rabbit C4b-binding protein alpha-chain. Preserved sequence motive in complement regulatory protein modules which bind C4b. Biochimica Et Biophysica Acta. 1261: 285-9. PMID 7711074 DOI: 10.1016/0167-4781(95)00019-D |
0.397 |
|
| 1995 |
Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thrombosis Research. 77: 1-43. PMID 7701473 DOI: 10.1016/0049-3848(94)00138-4 |
0.367 |
|
| 1995 |
Dahlbäck B. Molecular genetics of venous thromboembolism. Annals of Medicine. 27: 187-92. PMID 7632412 DOI: 10.3109/07853899509031957 |
0.355 |
|
| 1995 |
Dahlback B. Inherited resistance to activated protein C, a major basis of venous thrombosis, is caused by deficient anti-coagulant cofactor function of factor V Haematologica. 80: 102-113. PMID 7628762 |
0.322 |
|
| 1995 |
Arnljots B, Dahlback B. Antithrombotic effects of activated protein C and protein S in a rabbit model of microarterial thrombosis Arteriosclerosis, Thrombosis, and Vascular Biology. 15: 937-941. PMID 7600126 |
0.308 |
|
| 1995 |
De Frutos PG, Hardig Y, Dahlback B. Serum amyloid P component binding to C4b-binding protein Journal of Biological Chemistry. 270: 26950-26955. PMID 7592941 DOI: 10.1074/Jbc.270.45.26950 |
0.388 |
|
| 1995 |
Zoller B, He X, Dahlback B. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease Thrombosis and Haemostasis. 73: 743-745. PMID 7482396 DOI: 10.1055/S-0038-1653861 |
0.4 |
|
| 1995 |
Zoller B, Berntsdotter A, Garcia de Frutos P, Dahlback B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S Blood. 85: 3518-3523. DOI: 10.1182/Blood.V85.12.3518.Bloodjournal85123518 |
0.422 |
|
| 1995 |
Dahlbäck B. Resistance to Activated Protein C, the Arg506 to Gin Mutation in the Factor V Gene, and Venous Thrombosis Thrombosis and Haemostasis. 73: 739-742. DOI: 10.1055/S-0038-1653860 |
0.424 |
|
| 1994 |
Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. The New England Journal of Medicine. 330: 517-22. PMID 8302317 DOI: 10.1056/Nejm199402243300801 |
0.439 |
|
| 1994 |
Dahlback B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V Proceedings of the National Academy of Sciences of the United States of America. 91: 1396-1400. PMID 8108421 DOI: 10.1073/Pnas.91.4.1396 |
0.42 |
|
| 1994 |
Dahlback B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism Journal of Clinical Investigation. 94: 923-927. PMID 8083377 DOI: 10.1172/Jci117458 |
0.392 |
|
| 1994 |
He X, Dahlback B. Rabbit plasma, unlike its human counterpart, contains no complex between protein S and C4b-binding protein Thrombosis and Haemostasis. 71: 446-451. PMID 8052961 DOI: 10.1055/S-0038-1642458 |
0.423 |
|
| 1994 |
Zoller B, Svensson PJ, He X, Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C Journal of Clinical Investigation. 94: 2521-2524. PMID 7989612 DOI: 10.1172/Jci117623 |
0.346 |
|
| 1994 |
Dahlbäck B. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis. 24: 139-51. PMID 7959362 DOI: 10.1159/000217094 |
0.408 |
|
| 1994 |
Malm J, He XH, Bjartell A, Shen L, Abrahamsson PA, Dahlbäck B. Vitamin K-dependent protein S in Leydig cells of human testis. The Biochemical Journal. 845-50. PMID 7945211 DOI: 10.1042/Bj3020845 |
0.414 |
|
| 1994 |
Holm J, Zöller B, Svensson PJ, Berntorp E, Erhardt L, Dahlbäck B. Myocardial infarction associated with homozygous resistance to activated protein C. Lancet (London, England). 344: 952-3. PMID 7934361 DOI: 10.1016/S0140-6736(94)92302-7 |
0.345 |
|
| 1994 |
Zöller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet (London, England). 343: 1536-8. PMID 7911873 DOI: 10.1016/S0140-6736(94)92940-8 |
0.379 |
|
| 1994 |
Arnljots B, Bergqvist D, Dahlback B. Inhibition of microarterial thrombosis by activated protein C in a rabbit model Thrombosis and Haemostasis. 72: 415-420. PMID 7855793 DOI: 10.1055/S-0038-1648881 |
0.398 |
|
| 1993 |
Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C Proceedings of the National Academy of Sciences of the United States of America. 90: 1004-1008. PMID 8430067 DOI: 10.1073/Pnas.90.3.1004 |
0.409 |
|
| 1993 |
He X, Dahlback B. Molecular cloning, expression and functional characterization of rabbit anticoagulant vitamin-K-dependent protein S European Journal of Biochemistry. 217: 857-865. PMID 8223642 DOI: 10.1111/J.1432-1033.1993.Tb18314.X |
0.436 |
|
| 1992 |
Donnér M, Andersson AM, Kristoffersson AC, Nilsson IM, Dahlbäck B, Holmberg L. An Arg545----Cys545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease. European Journal of Haematology. 47: 342-5. PMID 1761120 DOI: 10.1111/J.1600-0609.1991.Tb01858.X |
0.409 |
|
| 1992 |
Dahlback B, Wiedmer T, Sims PJ. Binding of anticoagulant vitamin K-dependent protein S to platelet- derived microparticles Biochemistry. 31: 12769-12777. PMID 1463747 DOI: 10.1021/bi00166a009 |
0.364 |
|
| 1992 |
Schwalbe RA, Dahlbäck B, Coe JE, Nelsestuen GL. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine Biochemistry. 31: 4907-4915. PMID 1375509 DOI: 10.1021/Bi00135A023 |
0.407 |
|
| 1992 |
Malm J, Laurell M, Nilsson IM, Dahlbäck B. Thromboembolic Disease – Critical Evaluation of Laboratory Investigation Thrombosis and Haemostasis. 68: 007-013. DOI: 10.1055/S-0038-1656308 |
0.376 |
|
| 1991 |
Dahlback B. Protein S and C4b-binding protein: Components involved in the regulation of the protein C anticoagulant system Thrombosis and Haemostasis. 66: 49-61. PMID 1833851 DOI: 10.1055/S-0038-1646373 |
0.457 |
|
| 1991 |
Hesselvik JF, Malm J, Dahlbäck B, Blombäck M. Protein C, Protein S and c4b-Binding Protein in Severe lnfection and Septic Shock Thrombosis and Haemostasis. 65: 126-129. DOI: 10.1055/S-0038-1647469 |
0.307 |
|
| 1990 |
Hillarp A, Dahlback B. Cloning of cDNA coding for the β chain of human complement component C4b-binding protein: Sequence homology with the α chain Proceedings of the National Academy of Sciences of the United States of America. 87: 1183-1187. PMID 2300577 DOI: 10.1073/Pnas.87.3.1183 |
0.323 |
|
| 1990 |
Malm J, Cohen E, Dackowski W, Dahlbäck B, Wydro R. Expression of completely gamma-carboxylated and beta-hydroxylated recombinant human vitamin-K-dependent protein S with full biological activity. European Journal of Biochemistry. 187: 737-43. PMID 2137411 DOI: 10.1111/J.1432-1033.1990.Tb15361.X |
0.442 |
|
| 1990 |
Dahlback B, Hildebrand B, Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies Journal of Biological Chemistry. 265: 8127-8135. PMID 1692322 |
0.338 |
|
| 1990 |
Nilsson I, Berntorp E, Zettervall O, Dahlback B. Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients Blood. 75: 378-383. DOI: 10.1182/Blood.V75.2.378.Bloodjournal752378 |
0.319 |
|
| 1989 |
Dahlbäck B. A new model for coagulation factor V suggesting a unique mechanism of activation. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum. 191: 47-61. PMID 3247583 DOI: 10.1080/00365518809168293 |
0.308 |
|
| 1989 |
Hintner H, Stanzl U, Dahlbäck K, Dahlbäck B, Breathnach SM. Vitronectin shows complement-independent binding to isolated keratin filament aggregates. The Journal of Investigative Dermatology. 93: 656-61. PMID 2477464 DOI: 10.1111/1523-1747.Ep12319824 |
0.328 |
|
| 1988 |
Hillarp A, Dahlback B. Novel subunit in C4b-binding protein required for protein S binding Journal of Biological Chemistry. 263: 12759-12764. PMID 2970465 |
0.311 |
|
| 1988 |
Malm J, Bennhagen R, Holmberg L, Dahlback B. Plasma concentrations of C4b-binding protein and vitamin K-dependent protein S in term and preterm infants: Low levels of protein S-C4b-binding protein complexes British Journal of Haematology. 68: 445-449. PMID 2967718 DOI: 10.1111/J.1365-2141.1988.Tb04233.X |
0.311 |
|
| 1988 |
Malm J, Laurell M, Dahlback B. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception British Journal of Haematology. 68: 437-443. PMID 2967717 DOI: 10.1111/J.1365-2141.1988.Tb04232.X |
0.381 |
|
| 1988 |
Malm J, Dahlbäck B, Nilsson I. 387 Fibrinolytic studies in patients with congenital protein C or protein S deficiency Fibrinolysis. 2: 164. DOI: 10.1016/0268-9499(88)90734-5 |
0.399 |
|
| 1988 |
Dahlbäck B, Cohen EH, Dackowski WR, Malm J, Wydro RM. 362 Characterization of recombinant vitamin K-dependent protein S Fibrinolysis. 2: 154. DOI: 10.1016/0268-9499(88)90709-6 |
0.318 |
|
| 1987 |
Hillarp A, Dahlback B. The protein S-binding site localized to the central core of C4b-binding protein Journal of Biological Chemistry. 262: 11300-11307. PMID 2956264 |
0.306 |
|
| 1987 |
Stenflo J, Lundwall A, Dahlback B. β-Hydroxyasparagine in domains homologous to the epidermal growth factor precursor in vitamin K-dependent protein S Proceedings of the National Academy of Sciences of the United States of America. 84: 368-372. PMID 2948188 DOI: 10.1073/Pnas.84.2.368 |
0.576 |
|
| 1987 |
Malm J, Persson U, Dahlback B. Inhibition of human vitamin-K-dependent protein-S-cofactor activity by a monoclonal antibody specific for a Ca2+-dependent epitope European Journal of Biochemistry. 165: 39-45. PMID 2436912 DOI: 10.1111/J.1432-1033.1987.Tb11191.X |
0.433 |
|
| 1986 |
Podack ER, Dahlback B, Griffin JH. Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation Journal of Biological Chemistry. 261: 7387-7392. PMID 3754869 |
0.308 |
|
| 1986 |
Lundwall A, Dackowski W, Cohen E, Shaffer M, Mahr A, Dahlbäck B, Stenflo J, Wydro R. Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation. Proceedings of the National Academy of Sciences of the United States of America. 83: 6716-20. PMID 2944113 DOI: 10.1073/Pnas.83.18.6716 |
0.595 |
|
| 1986 |
Dahlback B. Inhibition of protein C(a) cofactor function of human and bovine protein S by C4b-binding protein Journal of Biological Chemistry. 261: 12022-12027. PMID 2943733 |
0.346 |
|
| 1986 |
Dahlback B, Lundwall A, Stenflo J. Primary structure of bovine vitamin K-dependent protein S Proceedings of the National Academy of Sciences of the United States of America. 83: 4199-4203. PMID 2940598 DOI: 10.1073/Pnas.83.12.4199 |
0.586 |
|
| 1986 |
Dahlback B, Lundwall A, Stenflo J. Localization of thrombin cleavage sites in the amino-terminal region of bovine protein S Journal of Biological Chemistry. 261: 5111-5115. PMID 2937785 |
0.334 |
|
| 1986 |
Dahlbäck B, Fernlund P, Stenflo J. Chapter 9B Inhibitors: protein C New Comprehensive Biochemistry. 13: 285-306. DOI: 10.1016/S0167-7306(08)60056-3 |
0.616 |
|
| 1985 |
Dahlbäck B, Podack ER. Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group. Biochemistry. 24: 2368-74. PMID 2581612 DOI: 10.1021/Bi00330A036 |
0.413 |
|
| 1984 |
Dahlback B. Interaction between vitamin K-dependent protein S and the complement protein, C4b-binding protein. A link between coagulation and the complement system Seminars in Thrombosis and Hemostasis. 10: 139-148. PMID 6234660 DOI: 10.1055/S-2007-1004416 |
0.406 |
|
| 1983 |
Suzuki K, Stenflo J, Dahlback B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C Journal of Biological Chemistry. 258: 1914-1920. PMID 6687387 |
0.323 |
|
| 1983 |
Dahlback B, Nilsson IM, Frohm B. Inhibition of platelet prothrombinase activity by a lupus anticoagulant Blood. 62: 218-225. PMID 6407549 DOI: 10.1182/Blood.V62.1.218.218 |
0.371 |
|
| 1983 |
Dahlbäck B, Hildebrand B. Degradation of human complement component C4b in the presence of the C4b-binding protein-protein S complex. The Biochemical Journal. 209: 857-63. PMID 6223626 |
0.314 |
|
| 1983 |
Dahlback B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S Biochemical Journal. 209: 847-856. PMID 6223625 |
0.314 |
|
| 1981 |
Dahlback B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein Proceedings of the National Academy of Sciences of the United States of America. 78: 2512-2516. PMID 6454142 DOI: 10.1073/Pnas.78.4.2512 |
0.614 |
|
| 1980 |
Dahlback B. Human coagulation factor V purification and thrombin-catalyzed activation Journal of Clinical Investigation. 66: 583-591. PMID 7400329 DOI: 10.1172/Jci109890 |
0.372 |
|
| 1980 |
Dahlbäck B, Stenflo J. The activation of prothrombin by platelet-bound factor Xa. European Journal of Biochemistry. 104: 549-57. PMID 7363904 DOI: 10.1111/J.1432-1033.1980.Tb04458.X |
0.566 |
|
| 1980 |
Dahlbäck B, Stenflo J. Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa. European Journal of Biochemistry. 107: 331-5. PMID 6893181 DOI: 10.1111/J.1432-1033.1980.Tb06033.X |
0.609 |
|
| 1979 |
Dahlbäck B, Stenflo J. Binding of bovine coagulation factor Xa to platelets. Biochemistry. 17: 4938-45. PMID 718867 DOI: 10.1021/Bi00616A013 |
0.567 |
|
| Show low-probability matches. |